Akebia Therapeutics names Dave Spellman as Senior Vice President, Chief Financial Officer and Treasurer

EFFECTIVE DATE:

Chartwell Partners is pleased to announce the recruitment of Dave Spellman as Senior Vice President, Chief Financial Officer and Treasurer for Akebia Therapeutics, (NASDAQ: AKBA), a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease.

 

https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-new-chief-financial-officer